Log In
Print
BCIQ
Print
Print this Print this
 

Comtan, entacapone

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionCatechol-O-methyl-transferase (COMT) inhibitor that inhibits breakdown of levodopa
Molecular Target Catechol-O-methyl-transferase (COMT)
Mechanism of ActionCatechol-O-methyl-transferase (COMT) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation

Partner

Orion Corp.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today